𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of Cyclophosphamide after prolonged low dose treatment in ovarian cancer patients

✍ Scribed by M. D’incalci; T. Facchinetti; G. Bolis; C. Mangioni; L. Morasca

Book ID
113006250
Publisher
Springer-Verlag
Year
1979
Tongue
English
Weight
385 KB
Volume
4
Category
Article
ISSN
0378-7966

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose intensive combination platinum and
Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer
✍ Jeremy D. Shapiro; Mace L. Rothenberg; Gisele A. Sarosy; Seth M. Steinberg; Debr 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## BACKGROUND. The authors combined cisplatin and carboplatin together with cyclophosphamide to maximize platinum dose intensity in patients with advanced epithelial ovarian cancer (AOC). ## METHODS. The authors treated 26 consecutive, newly diagnosed patients with International Federation of G

Bladder malignancy in a patient receivin
Bladder malignancy in a patient receiving low dose cyclophosphamide for treatment of rheumatoid arthritis
✍ Alan F. Ansher; John W. Melton III; Anthony J. Sliwinski 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 3 views

Cyclophosphamide treatment of malignant disease has been strongly associated with an increased incidence of bladder cancer. Recently there have been 3 papers reporting 4 cases of bladder cancer in patients treated with cyclophosphamide for benign disease (1-3). However, there is no increased inciden